Stockwinners Market Radar for October 24, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:22 EDT Noodles & Co shareholders elect not to proceed with offering of 10.1M shares - Noodles & Company announced that certain of its stockholders have elected not to proceed with the previously announced plans to pursue an underwritten secondary offering of up to 10,062,500 shares of its Class A common stock at this time due to market conditions.

19:32 EDT EQT Corporation names James Rohr as chairman of board - EQT Corporation announced that it has appointed four new members to its board of directors, effective upon completion of the separation of the Company's upstream and midstream businesses, which is expected to occur at 11:59 p.m. Eastern Time on November 12, 2018. Additionally, Robert J. McNally, currently EQT's chief financial officer, who will become president and chief executive officer of EQT post-separation, will join the board of directors for EQT; and James E. Rohr will become chairmain of the EQT board of directors, taking over for David L. Porges.

19:20 EDT Tesla CEO: No plans to raise equity or debt at this time, but this may change

19:08 EDT Tesla CEO: See a pathway to make 7K Model 3 cars per week with 'minimal' capex

19:06 EDT Tesla CEO: Aim for annual global output of 500K to 1M Model 3 cars long term

18:58 EDT Tesla says cell supply still somewhat tight but is expanding - Says there is a "steady increase in the total supply". Comments from Q3 earnings call Q/A.

18:40 EDT Wells Fargo says CAO Hardison, chief auditor Julian begin leaves of absence - Wells Fargo announced that Chief Administrative Officer Hope Hardison and Chief Auditor David Julian have begun leaves of absence from Wells Fargo and will no longer be members of the company's Operating Committee. These leaves relate to previously disclosed ongoing reviews by regulatory agencies in connection with historical retail banking sales practices. These leaves of absence are unrelated to the company's reported financial results or internal financial controls.

18:10 EDT Microsoft says expects FY operating margin to increase, despite Github

18:06 EDT Nvidia falls after AMD CEO says 'graphics channel sales were lower' - "Client and server processor sales increased significantly although graphics channel sales were lower in the quarter. Looking forward, we believe we are well positioned for further market share gains as we continue making significant progress towards our long-term financial targets," said AMD (AMD) CEO Lisa Su in tonight's Q3 earnings release. Shares of Nvidia, another graphics chip maker, are down 3% in the after-hours after falling almost 10% in the regular session. Nvidia (NVDA) is almost $6 lower in after-hours trading to $193.52 per share, while AMD is down 20.54% to $18.11 per share.

17:58 EDT Washington Prime reports Q3 FFO 37c, consensus 36c - Reports Q3 revenue $179.92M, consensus $179.22M. Reports Q3 EPS 0c, one estimate 3c.

17:47 EDT Renasant raises annual dividend rate to 84c per share from 80c - The board of directors of Renasant Corporation approved the payment of a quarterly cash dividend of 21c per share to be paid January 1, 2019, to shareholders of record as of December 18, 2018. This action boosts the cash dividend from the current annual rate of 80c per share to 84c per share.

17:46 EDT Renasant board authorizes up to $50M share repurchase - Renasant's board has authorized the repurchase of up to $50M of the company's outstanding common stock, either in open market purchases or privately-negotiated transactions. The stock repurchase program will remain in effect for one year or, if earlier, the repurchase of the entire amount of common stock authorized to be repurchased by the board of directors.

17:45 EDT Ford raises annual dividend rate to 84c per share from 80c - The board of directors of Renasant Corporation approved the payment of a quarterly cash dividend of 21c per share to be paid January 1, 2019, to shareholders of record as of December 18, 2018. This action boosts the cash dividend from the current annual rate of 80c per share to 84c per share.

17:44 EDT Vale approves $1.1B investment in Salobo III copper project - Vale will receive a bonus ranging from approximately $600M-$700M from Wheaton Precious Metals, after achieving certain production targets.

17:43 EDT Vale says Q3 results translated to shareholder remuneration of $1.142B - Q3 results translated into a minimum shareholder remuneration of $1.142B, Vale said. If the company delivers the same results next quarter, its minimum dividend related to the second half, according to its policy, will be $2.3B, against $1.9B in the first half, the company said.

17:39 EDT Jacobs Engineering, Tetra Tech among competitors for $100M Army contract orders - Jacobs Government Services (JEC) and Tetra Tech (TTEK) are among competitors for orders on the $100M firm-fixed-price contract for architect and engineer services. Bids were solicited via the internet with 10 received. Work locations and funding will be determined with each order, with an estimated completion date of Oct. 23, 2023. U.S. Army Corps of Engineers is the contracting activity.

17:30 EDT Honeywell awarded $1.04B Defense Logistics Agency contract - Honeywell has been awarded an estimated $1.04B firm-fixed-price requirements contract for support of the following platforms: Ground Start Carts, C-130 Auxiliary Power Units, or APU, B-2 APU, F-15 components, A-10 APU, E-3 APU, B-1 APU and F-16 turbine power units. This was a sole-source acquisition using justification 10 U.S. Code 2304, as stated in Federal Acquisition Regulation 6.302-1. This is a three-year, six-month base contract with one three-year option and one three-year and six-month option period. Using military service is Air Force. Location of performance is Utah, with a July 31, 2028, performance completion date. Type of appropriation is FY19 through 2029 Air Force working capital funds. The contracting activity is the Defense Logistics Agency Aviation.

17:30 EDT Sleep Number sees FY18 gross margin 60.5% - Says confident it took market share in Q3. Says NFL sponsorship links sleep number beds with performance. Says adding stores in markets with competitor closures. Says there are headwinds from tariffs and freight costs going forward. Says FY18 EPS midpoint view of $1.85 means adjusted Q4 earnings should improve 52%. Sees FY18 gross margin 60.5%. Comments taken from Q3 earnings conference call.

17:18 EDT Kilroy Realty reports Q3 occupancy 93.5% vs. 94.0% last year

17:09 EDT Agnico Eagle raises FY18 production outlook to 1.60M oz from 1.58M oz - CEO Sean Boyd says: "On the back of another strong operational quarter, we have once again increased our 2018 production guidance. We now expect to produce approximately 1.60 million ounces, up from our previous forecast of 1.58 million ounces that was announced last quarter. Total cash costs and AISC are expected to be at or slightly below the mid-point of our guidance range... Our Nunavut development projects are progressing well. Drilling continues to generate positive exploration results from the Amaruq underground deposits and we see potential for a slightly earlier startup at Meliadine. As a result, we now expect our 2019 gold production to exceed 1.70 million ounces, which was the mid-point of the previous 2019 guidance".

17:04 EDT Goldcorp says proven, probable gold mineral reserves are 52.8M ounces - Goldcorp provided an update to the company's Mineral Reserve and Mineral Resource estimates as of June 30, 2018. Goldcorp is also providing an update on its 2018 exploration program with representative drill results provided below; website links to further information, including full drill results, drill coordinates, quality assurance and quality control information and relevant diagrams, are provided at the end of each section. Proven and Probable Gold Mineral Reserves are 52.8 Million Ounces. Goldcorp mineral reserves increased at Musselwhite with the higher-grade extension of PQ Deeps and the addition of the WEL zone and at Cerro Negro, with an inaugural mineral reserve estimate at the Silica Cap deposit. Overall mineral reserves additions at Goldcorp-operated sites essentially replaced depletion over the 12-month period. Musselwhite and Cerro Negro continue to deliver exploration success. At Musselwhite, Lynx North drill intercept highlights included 10.3 m at 6.68 g/t gold and 9.4 m at 6.06 g/t gold and extended the strike length of the known Lynx North orebody 500 m to the north. Surface drilling from the north shore intersected PQ Deeps 1.2 km down plunge of the 2018 mineral reserves, returning intercepts of 9.2 m at 10.92 g/t gold and 9.8 m at 5.05 g/t gold. At Cerro Negro the newly discovered Ricarda vein returned drill intersections of 9.25 m at 5.28 g/t gold and 3.9 m at 11.53 g/t gold. Goldcorp's 20/20/20 plan continues on track to deliver 20% reserve growth by 2021. Goldcorp has increased reserve ounces by 2.8 million since beginning the 20/20/20 plan in 2017 and remains positioned to deliver 20% reserve growth by 2021. Goldcorp's proven and probable gold mineral reserves as of June 30, 2018 totaled 52.8 million ounces, compared to 53.5 million ounces as of June 30, 2017 as exploration success at our operated mines essentially replaced mineral reserves depletion from production. A small net loss in mineral reserves, from depletion, was experienced at our non-operated mines, including Pueblo Viejo.

17:03 EDT Oceaneering sees Q4 results lower than Q3 - Management said, "Looking forward, we believe our fourth quarter 2018 results will be lower than our adjusted third quarter results due to the onset of seasonality leading to reduced levels of offshore energy activity. Sequentially, we expect lower operating income from each of our energy segments, with most of the decline expected to be in Subsea Products and Subsea Projects segments. Additionally, in our Subsea Products segment we are expecting an unfavorable impact at our manufacturing facility in Panama City, Florida due to damage caused by Hurricane Michael in mid-October 2018. For our non-energy segment, Advanced Technologies, we are projecting a quarterly improvement in operating income. Unallocated Expenses are expected to be in the upper-$20 million range. For the full year of 2018, we currently expect our adjusted EBITDA to be in the lower half of the guidance range of $140 million to $160 million. And, we continue to expect each of our operating segments will contribute positive EBITDA. We are encouraged that the long-term fundamentals for the offshore energy industry have stabilized and we believe we are now in the early stages of a recovery in activity in general, and in our businesses. We expect a recovery will take time, and only after a sustained higher level of activity can prices for our services and products be increased enough to generate satisfactory returns. Accordingly, looking into 2019, we are projecting increased activity levels in each of our segments, likely led by revenue gains in our Subsea Products manufacturing business unit. However, the pace of recovery is still difficult to determine, and at this time we are not prepared to offer more detailed guidance on 2019."

16:58 EDT Whirlpool up 8.9% after Q3 earnings beat and raised FY18 EPS midpoint view

16:57 EDT Xilinx up over 11% afterhours following Q2 earnings beat and raised FY19 view

16:52 EDT LeMaitre acquires Cardial Business of Becton Dickinson - LeMaitre Vascular (LMAT) announced that it has acquired the assets of Cardial, a subsidiary of Becton Dickinson (BDX), located in Saint-Etienne, France. The total purchase price for the acquired assets was EURO$2.0M, structured as EURO$1.1M of cash at closing, EURO$0.5M of assumed liabilities, and EURO$0.4M of post-closing installments. LeMaitre Vascular expects the acquired business to contribute $0.3M in sales and $1.6M in operating income in Q4. The operating income contribution includes an estimated $1.7M gain resulting from the excess of the value of the assets acquired over the purchase price.

16:49 EDT Financial Institutions names Justin Bigham deputy CFO - Financial Institutions announced that Justin Bigham was named executive VP and deputy CFO. Earlier this year, the company announced that Kevin Klotzbach will step down as CFO effective March 31, 2019, at which time Bigham will assume the role. Klotzbach will continue to support the company through December 31, 2019, to ensure a successful transition.

16:39 EDT KLA-Tencor announces plans to establish R&D facility in Ann Arbor, Michigan - KLA-Tencor has announced plans to establish a research-and-development center in Ann Arbor, Michigan. The development is expected to include a total capital investment of more than $70M and create up to 500 new high-tech jobs in the region over the next five years.

16:37 EDT Oneok raises quarterly dividend 4% to 85.5c per share - The dividend is payable Nov. 14 to shareholders of record at the close of business Nov. 5.

16:35 EDT HFF announces sale of apartment property in Wheaton, IL - Holliday Fenoglio Fowler announces the sale of Wheaton Center, a 758-unit, multi-building apartment property in the west Chicago suburb of Wheaton, Illinois. The HFF team represented the seller, a joint venture between Draper and Kramer, Incorporated and Edge Principal Advisors LLC, in the sale of the property to the buyer, FPA Multifamily, LLC. The property was purchased free and clear of existing financing.

16:34 EDT Chubb appoints Joe Vasquez to lead Global Accident & Health Business - Chubb announced that Joe Vasquez has been named Senior Vice President, Chubb Group and head of the company's global accident and health insurance business. He currently serves as President of ESIS, Inc., the company's third party risk management and claims services affiliate. In his new role, Vasquez will be responsible for Chubb's $4B personal accident and supplemental health insurance business around the world, including the operations of Combined Insurance. The appointment is effective immediately. Ed Clancy, Executive Vice President, Chubb Group, Global Accident & Health and Life, and a longtime company executive who has led the A&H business since 1999, will retire from the company in March 2019. Clancy will work closely with Vasquez on the leadership transition of the business until that time.

16:30 EDT Twilio names Khozema Shipchandler as new CFO - Twilio announced that Khozema Shipchandler will join as the company's chief financial officer, effective Nov. 12, 2018. Shipchandler brings more than 20 years of business strategy and corporate finance leadership to the role. At Twilio, Shipchandler will oversee the company's accounting, business intelligence, corporate development, facilities, finance and technical operations teams. He will report to Twilio's co-founder and chief executive officer Jeff Lawson.

16:29 EDT Visa reports Q4 payments volume up 11% - Total processed transactions, which represent transactions processed by Visa, for the three months ended September 30, 2018, were 32.8B, up 12% over the prior year. Q4 cross-border volume were up 10%. Q4 processed transactions were up 12%.

16:28 EDT Kraton cuts FY18 adjusted EBITDA view to approximately $380M from $400M - "Our outlook for the balance of 2018 must be tempered by uncertainty around global demand fundamentals, the impact of tariffs and trade negotiations with China and other factors including ongoing inflation in logistics costs. In addition, we expect our fourth quarter results to reflect the impact of a post-turnaround delay of approximately three weeks in start-up at our Wesseling, Germany, plant associated with unusually low water levels on the Rhine River. In light of these factors, and given our third quarter results, we now expect our full year 2018 Adjusted EBITDA to be approximately $380 million, excluding any fourth quarter 2018 impact associated with the Panama City, Florida, outage," CEO Fogarty stated.

16:26 EDT Whirlpool announces actions to right-size its business in EMEA region - "Very impressive results in North America and a favorable tax rate allowed us to deliver our highest quarterly ongoing EPS in our long history, demonstrating our ability to overcome the numerous external challenges we have been facing," said Marc Bitzer, chief executive officer of Whirlpool Corporation. "While our EMEA performance has been disappointing, our progress on restoring volume and the new actions to refocus and right-size our business give us confidence that we can turn around the region."

16:22 EDT Kadmon announces departure of CFO Konstantin Poukalov - Kadmon Holdings announced that Konstantin Poukalov has notified the company of his intent to step down as executive VP, CFO and Principal Accounting Officer, or PAO, effective immediately. Kyle Carver, the company's controller, has been appointed PAO while the company searches for a new CFO. Kadmon noted that Poukalov's decision to resign was not related to any issues regarding the company's financial statements or accounting practices.

16:21 EDT Tesla sees 2018 capex 'slightly below' $2.5B - Tesla said: "Our total 2018 capex, the vast majority of which is to grow our capacity, is expected to be slightly below $2.5B, consistent with our prior guidance. Our Q4 capex projection includes the purchase of land in China and initial design and other expenditures for Gigafactory 3. Interest expenses in Q4 should be roughly $170M and losses attributable to noncontrolling interests should decline significantly compared to Q3."

16:20 EDT Tesla backs target of delivering 100,000 Model S and X this year

16:19 EDT Tesla delivered 27,710 Model S and X vehicles in Q3 - Tesla said: "In Q3, we delivered 27,710 Model S and X vehicles to customers. While demand in China remains challenging due to a 40% import duty for Model S and X, China deliveries still remained a material portion of our Q3 deliveries, and we managed to offset the decline there with growth in North America and Europe."

16:19 EDT Tesla says Model 3 production averaged 4,300 per week in Q3 - Tesla said: "Q3 2018 was a truly historic quarter for Tesla. Model 3 was the best-selling car in the US in terms of revenue and the 5th best-selling car in terms of volume. With average weekly Model 3 production through the quarter, excluding planned shutdowns, of roughly 4,300 units per week, we achieved GAAP net income of $312M. We also delivered on our internal cost efficiency targets, leading to GAAP Model 3 gross margin of more than 20%, which exceeded our guidance. Finally, our total cash increased by $731M and we had free cash flow of $881M despite less than 10% of that amount coming from key working capital items."

16:17 EDT Brookline Bancorp increases quarterly dividend 5% to 10.5c per share - The company's board approved a dividend of 10.5c per share for the quarter ended September 30, representing an increase of 5%. The dividend will be paid on November 23, to stockholders of record on November 9. This is the second increase in the quarterly common dividend this year and represents a year over year increase in the quarterly dividend of 16.7%.

16:16 EDT Whirlpool sees FY18 adjusted free cash flow approximately $600M - Excluding the impact of discrete voluntary items, free cash flow is anticipated to be approximately $800M.

16:16 EDT Sarepta down 2.5% after reporting Q3 earnings results

16:14 EDT Whirlpool cuts FY18 operating cash flow view to approximately $1.2B from $1.5B

16:12 EDT Galapagos NV, AbbVie restructure CF alliance, Galapagos to receive $45M - Galapagos NV (GLPG) and AbbVie (ABBV) announce a restructuring of their cystic fibrosis, or CF, alliance. AbbVie takes over all programs in CF and continues the development of a triple combination therapy for CF. AbbVie will obtain exclusive worldwide rights to the current CF investigational drug candidate portfolio developed by the two companies in the course of the collaboration. The portfolio includes all potentiator and corrector candidates. AbbVie will be responsible for all future activities and will bear all costs associated with this portfolio in CF going forward. Galapagos will receive an upfront payment of $45M from AbbVie. Galapagos will be eligible to receive up to $200M in additional milestone payments from AbbVie pending completion of certain development, regulatory, and commercial achievements in CF by AbbVie. In the event AbbVie receives regulatory approval and realizes commercial sales in CF, Galapagos is further eligible to receive royalties ranging from single digit to low teens. AbbVie further agrees to pay Galapagos tiered single digit royalties of global commercial sales, if approved, from these candidates achieved in indications outside of CF. Galapagos retains exclusive global commercial rights to develop GLPG2737, a candidate C2 corrector, in all indications outside of CF. AbbVie is eligible for future milestone payments and tiered single digit royalties on future global commercial sales, if approved, in indications outside CF.

16:08 EDT Microsoft shares up 31c to $102.63 following Q1 results

16:08 EDT Microsoft sees 'continued demand' for cloud offerings - Satya Nadella, CEO of Microsoft, said in today's earnings release, "We are off to a great start in fiscal 2019, a result of our innovation and the trust customers are placing in us to power their digital transformation. We're excited to help our customers build the digital capability they need to thrive and grow, with a business model that is fundamentally aligned to their success." Amy Hood, CFO, added, "Our record results for Q1 reflect our commitment to long-term strategic investments and consistent execution to drive revenue growth and operating margin expansion. We see continued demand for our cloud offerings, reflected in our commercial cloud revenue of $8.5 billion, up 47% year over year."

16:05 EDT Microsoft reports LinkedIn revenue up 33% - Reports Q1 Office commercial products and cloud services revenue up 17%, Windows OEM revenue up 3%.

16:03 EDT PTC reports Q4 subscription revenue $544M, up 61% from last year

15:53 EDT Azul, Turkish Airlines enhance cooperation with frequent flyer pact - Azul and Turkish Airlines announced the enhancement of their cooperation with a frequent flyer agreement between the two airlines' loyalty programs. Starting today, members of Azul's loyalty program TudoAzul and members of Turkish Airlines loyalty program Miles&Smiles will have access to exclusive benefits and the ability to earn and redeem points when flying on each airline. This new frequent flyer agreement builds upon the very successful codeshare agreement between Turkish and Azul that was implemented in December 2017. Via this codeshare agreement customers traveling on a connecting itinerary between the two airlines can enjoy a seamless travel experience and connect to over 100 destinations in Brazil.

15:14 EDT Arris trading resumes

15:08 EDT Arris jumps after report of CommScope takeover talks - Shares of Arris (ARRS) are moving higher in afternoon trading after Reuters reported, citing sources, that CommScope (COMM) is in talks to acquire the set-top box maker. Following Reuters' report, Arris shares are up 40c, or 2%, to $22.94. The stock had been in negative ground prior to the story.

14:52 EDT Rite Aid 'applauds' enactment of SUPPORT bill to fight opioid abuse - Rite Aid said it applauded the enactment of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act. A key provision of the new law aims to address the opioid epidemic by expanding eligibility for at-risk seniors to receive Medication Therapy Management counseling services from pharmacists through Medicare Part D. Through MTM services, pharmacists help patients take their prescription drugs properly and follow a drug therapy regimen. Executive Vice President of Pharmacy Jocelyn Konrad represented Rite Aid as an invited guest at the White House as President Trump signed the bill into law. "We applaud President Trump for signing the 'SUPPORT for Patients and Communities Act' and taking action to help combat the opioid crisis," said Konrad. "This law will enable our pharmacists to play a larger role in these efforts by providing Medication Therapy Management counseling services to at-risk seniors through Medicare Part D. This represents an important step in further empowering our pharmacists to provide additional care that can help lower overall healthcare costs and address critical public health issues."

13:54 EDT Ameren unit reaches milestone in plans to build Missouri wind facility - The largest-ever wind facility in Missouri is one step closer to producing renewable energy. This morning, the Missouri Public Service Commission voted unanimously to grant Ameren Missouri, a subsidiary of Ameren, a certificate of convenience and necessity to acquire, after construction, a 400-megawatt facility that is expected to be located in Schuyler and Adair counties in northeast Missouri. "This is an important next step in the process to develop more renewable energy in the state for the long-term benefit of our customers," said Michael Moehn, president of Ameren Missouri. More milestones remain for the northeast Missouri facility, including obtaining a timely and acceptable Midcontinent Independent System Operator transmission interconnection agreement.

13:36 EDT Ameren unit reaches milestone in in plans to build Missouri wind facility - The largest-ever wind facility in Missouri is one step closer to producing renewable energy. This morning, the Missouri Public Service Commission voted unanimously to grant Ameren Missouri, a subsidiary of Ameren, a certificate of convenience and necessity to acquire, after construction, a 400-megawatt facility that is expected to be located in Schuyler and Adair counties in northeast Missouri. "This is an important next step in the process to develop more renewable energy in the state for the long-term benefit of our customers," said Michael Moehn, president of Ameren Missouri. More milestones remain for the northeast Missouri facility, including obtaining a timely and acceptable Midcontinent Independent System Operator transmission interconnection agreement.

13:19 EDT New York sues Exxon Mobil for misleading investors on climate change - New York Attorney General Barbara Underwood announced a lawsuit against Exxon Mobil, alleging that the company "misled investors regarding the risk that climate change regulations posed to its business."As alleged in the complaint, Exxon "for years assured investors that it was accounting for the likelihood of increasingly stringent regulation of greenhouse gas emissions - which are driving climate change and which Exxon emits in large quantity - by rigorously and consistently applying an escalating cost of those emissions to its business planning, investment decisions, calculations of the amount and value of company reserves and resources, impairment assessments, and projections of future demand for oil and gas." Exxon, however, "did not abide by these representations, and instead did much less than it claimed, deceiving investors as to the company's true financial exposure to increasing regulations and policies adopted to mitigate the adverse effects of climate change," claims Underwood. Shares of Exxon Mobil are down 1%, or $1.06, to $78.78 in afternoon trading. Reference Link

13:12 EDT Street Fight: Argus cuts Paccar rating on valuation, Piper says buy - Piper Jaffray analyst Alexander Potter upgraded Paccar (PCAR) to Overweight following his firm's fifth annual truck brand survey, which he believes bodes well for the company's pricing and market share. Not as bullish, his peer at Argus cut his rating on the stock to Hold as he believes Paccar's shares are "fairly valued." ARGUS MOVING TO THE SIDELINES: In a research note to investors, Argus analyst John Eade downgraded Paccar to Hold from Buy, saying its shares are "fairly valued" near $57. The analyst acknowledged that due to an industry-wide driver shortage, many operators choose Paccar trucks in an attempt to attract and retain drivers, which he believes is reflected in the company's recent market share gains. Orders for heavy-duty trucks in North America, which fell during the 2011-2017 period, are growing again, he noted, adding that the European market is also showing strength. That said, Eade thinks recent deteriorating growth rates for Paccar indicate that the cyclical market is "near full recovery." From a technical standpoint, "the shares pattern has shifted and the shares have recently been in a bearish trend of lower highs and lower lows that dates to January 2018," he added. Eade would look to move this well-managed company back to his Buy rating list if he sees a pick-up in the industry or more share price stability. Meanwhile, Baird analyst David Leiker argued in a research note of his own that Paccar has underperformed and said he expects additional pressures as investors discount a 2019 cycle peak. He believes the 2019 set up looks challenging for the truck group, citing periods of decelerating or declining order growth. Nonetheless, the analyst said once the cycle turns, Paccar will be one of the first names he revisits. Leiker reiterated an Underperform rating and lowered his price target to $57 from $59 on Paccar shares. PIPER SAYS BUY PACCAR: Following his firm's fifth annual truck brand survey, Piper Jaffray's Potter upgraded Paccar to Overweight, with a $67 price target. The analyst noted that 743 U.S.-based fleets responded to the survey, and like in previous years, Paccar's brands boasted the highest level of brand loyalty. Potter thinks the survey bodes well for the company's pricing and market share, and he would be buying the stock following its recent selloff. Paccar has no debt, a 4% dividend yield, an active buyback program, and a current valuation of 9 times FY19 EPS, the lowest in nearly a decade, he contended. PEER RATING CUT AT PIPER: Piper Jaffray's Potter pointed out that, by contrast, Navistar's (NAV) survey scores were weaker than expected, and with interest rates rising, he thinks investors will favor stocks with less leverage. The analyst downgraded the stock to Neutral from Overweight and lowered his price target on the shares to $37 from $44. Navistar's market share fell by more than 50% after an emissions crisis nearly drove the company into bankruptcy, he noted, adding that with a refreshed product lineup and backing from Volkswagen (VLKAY), he still expects the company to win back some of these losses. However, the analyst noted that after reviewing the results from his survey, he now expects Navistar's share to rise more slowly than he had originally anticipated. PRICE ACTION: In afternoon trading, shares of Paccar have dropped almost 4% to $55.33.

13:06 EDT Independent Bank reestablishes buyback with $75M program, declares dividend - Independent Bank Group announced that its board has declared a quarterly cash dividend in the amount of 14c per share of common stock. The dividend will be payable on November 15 to stockholders of record as of the close of business on November 5. Independent Bank Group also announced that the Board of Directors has reestablished a share repurchase program which authorizes the repurchase of up to $75M of its common stock. The company plans to repurchase its shares in open market transactions from time to time or through privately negotiated transactions, at the company's discretion. Commenting on the announcement David R. Brooks, Chairman and CEO, said, "Given the current market for bank stock prices, we believe that now is a good time for us to reestablish a share repurchase program. This program gives us an additional tool with which to enhance shareholder value. We plan to implement the program at such time and price as repurchases are considered beneficial to the Company and its stockholders." Brooks continued, "The Board's approval of a stock repurchase program reflects continued confidence in our ability to execute the Company's key strategies."The repurchase program is authorized to continue through October 1, 2019.

13:01 EDT Genentech announces FDA approval of Xofluza for influenza - Genentech, a member of the Roche Group, announced that the U.S. FDA has approved XOFLUZA for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. XOFLUZA is a first-in-class, single-dose oral medicine with a novel proposed mechanism of action that inhibits polymerase acidic endonuclease, an enzyme essential for viral replication. XOFLUZA has demonstrated efficacy against a wide range of influenza viruses, including oseltamivir-resistant strains and avian strains in non-clinical studies. XOFLUZA was approved based on results from the Phase III CAPSTONE-1 study of a single dose of XOFLUZA compared with placebo or oseltamivir 75 mg, twice daily for five days, in otherwise healthy people with the flu, as well as results from a placebo-controlled Phase II study in otherwise healthy people with the flu. XOFLUZA significantly reduced the duration of flu symptoms compared to placebo, and demonstrated similar efficacy compared to oseltamivir. In clinical trials, XOFLUZA was safe and well-tolerated with a side effect profile similar to placebo. The CAPSTONE-1 and Phase II study results were recently published in the September 6, 2018 issue of the New England Journal of Medicine. XOFLUZA will be available across the U.S. in the coming weeks.

12:50 EDT Tesla Model S, Honda Odyssey lose CR recommendation over reliability issues - Because of reliability problems reported by car owners to Consumer Reports, 12 models -- including the Honda (HMC) Odyssey minivan and Tesla (TSLA) Model S sedan -- lost their recommendations today, Consumer Reports says. "Our list of CR recommended vehicles is determined, in part, by how the vehicles perform in CR's exclusive Annual Reliability Survey. This year we collected data from CR members on more than 500,000 vehicles." CR says Tesla's Model S lost its recommendation "largely because of suspension problems reported by CR members in the survey. Tesla made air suspension and all-wheel drive standard in its 2017 Model S." A Tesla spokeswoman told CR that some Model S owners experienced suspension problems primarily in 2017. She said that the problem was supplier-related and that the automaker already had addressed it. She pointed out that there was an unrelated false service alert that some customers received this year regarding their suspension. That problem was corrected via an over-the-air software update within two weeks of being reported, she said. The Odyssey minivan had much-worse-than-average reliability, with problems including the infotainment display freezing and losing all functionality, and power sliding doors that wouldn't close. The Honda spokesman said that the automaker released over-the-air software updates. Software updates issued by Honda can be downloaded by the customer using any WiFi connection. As for the door problem, the spokesman said Honda is aware of some instances, and plans to issue a service bulletin with specific dealer repair guidance soon. Reference Link

12:22 EDT Northrop Grumman continues to see 'strong' demand from international customers - Says capital deployment strategy remains the same. Says remains 'on track' to meet or exceed cost reduction target from integration. Says will be consolidating two TS business units into one. Says share repurchases remain an important component of capital deployment strategy. Comments taken from Q3 earnings conference call.

12:08 EDT Bruce D. Hansen reports 6.7% stake in General Moly

12:00 EDT Butterfield falls -26.0% - Butterfield is down -26.0%, or -$13.32 to $37.83.

12:00 EDT Tupperware Brands rises 15.1% - Tupperware Brands is up 15.1%, or $4.89 to $37.25.

12:00 EDT K12 rises 25.9% - K12 is up 25.9%, or $4.49 to $21.82.

11:45 EDT Turkcell trading resumes

11:35 EDT Spotify says playlist submission feature is officially out of beta - "Our playlist submission feature is officially out of beta. A few months ago, we unveiled a beta feature in the Spotify for Artists tool that gives artists, labels, and teams the ability to share new music directly with our editorial team for playlist consideration. Since the feature became available in July more than 67,000 artists and labels have submitted music and now we're excited to announce our playlist submission feature is officially out of beta," said Spotify in a blog posting. Reference Link

11:14 EDT National CineMedia names Rick Butler as Chief Digital Officer - National CineMedia has named Rick Butler to the role of Chief Digital Officer. In his new role, Butler will lead the company's digital products and data initiatives. Prior to this, Butler had been working with the NCM Digital team as a consultant as President of Playa Vista Consulting.

11:10 EDT Forward Pharma trading resumes

11:07 EDT Goldman says buy Lockheed amid uncertainty surrounding Saudi deal - This morning, Goldman Sachs analyst Noah Poponak upgraded Lockheed Martin to Buy saying it increasingly looks to have outgrowth differentiators in the Defense market. Separately, Bloomberg reported that the company's $15B sale of its THAAD missile system to Saudi Arabia may be at risk in the aftermath of the murder of journalist Jamal Khashoggi. BUY LOCKHEED MARTIN: In a research note to investors, Goldman Sachs' Poponak upgraded Lockheed Martin to Buy from Neutral and added the shares to his firm's Conviction List. The analyst believes Lockheed increasingly looks to have outgrowth differentiators in an end-market he favors, namely Defense, and sees margins expanding from current levels in every segment. Further, Poponak argued that free cash can convert at a high rate for a long time and said he sees upside to consensus estimates. The recent pullback in shares makes the stock's valuation more attractive, he added. Additionally, the analyst continues to expect higher future defense spending than the market discounts and now sees greater potential for outgrowth given developments in missile, missile defense, helicopters and space, in addition to remaining F-35 growth. Poponack told investors he also thinks Lockheed can beat current 2019/2020 cash flow guidance, potentially by a wide margin. The analyst raised his price target on the shares to $394 from $391. SAUDI ARABIA DEAL UNCERTAINTY: Lockheed Martin's $15B sale of its THAAD missile system to Saudi Arabia may be at risk in the aftermath of the murder of journalist Jamal Khashoggi at the Saudi consulate in Turkey, according to Bloomberg. The pending Saudi deals for arms, logistics and training includes sales started during President Barack Obama's administration, and only $14.5B of that involves signed "letters of offer and acceptance" that spell out final terms and prices. Citing the company's CEO Marillyn Hewson, the Washington Post said Lockheed would defer to the U.S. government's decisions regarding relations with the kingdom. "Most of these agreements that we have are government-to-government purchases, so anything that we do has to follow strictly the regulations of the U.S. government," she said in response to a question from Bernstein analyst Doug Harned during the company's earnings call yesterday. "Beyond that, we'll just work with the U.S. government as they're continuing their relationship with Saudi." PRICE ACTION: In morning trading, shares of Lockheed Martin have dropped over 2% to $313.91.

11:01 EDT Boeing says on track with capital deployment program - Boeing management said the company is on track with the balance of its capital deployment. The company was granted supplemental type certification for KC-46 Tanker program. The company is in continued talks to close JV with Embraer. Comments provided during Q3 earnings conference call.

10:37 EDT XBiotech announces dismissal of class action lawsuit - XBiotech announced that the honorable Judge Dustin M. Howell of the 459th Travis County District Court has issued a letter ruling granting the company's Motion to Dismiss the securities class action complaint brought against XBiotech. The District Court has directed the parties to prepare a formal order memorializing the ruling. On December 1, 2015, a purported securities complaint was filed against the Company, certain of its officers and directors and the underwriter for its initial public offering in the Superior Court for the State of California, Los Angeles County. At a June 2017 hearing before the Superior Court for the State of California, Los Angeles County, the judge ruled that the case belonged in Texas, not in California. The plaintiffs re-filed their suit in Travis County District Court in July 2017. The county court ultimately heard arguments on XBiotech's motion to dismiss and issued the letter ruling granting the dismissal. Two federal cases were previously filed in the U.S. District Court for the Western District of Texas, but both of those cases have also been dismissed.

10:24 EDT Freeport McMoRan sees no major changes on PT-FI outlook

10:16 EDT Freeport McMoRan says copper uncertainty slowing LT building plans - Says to defer investment decisions until more certainty.

10:14 EDT Freeport McMoRan: LT copper fundamentals 'increasingly strong'

10:03 EDT Virtusa collaborates with BIAN to develop API Exchange - Virtusa Corporation announced its collaboration with the Banking Industry Architecture Network to launch BIAN's API Exchange. BIAN's API Exchange, developed collaboratively by a group including Virtusa, BIAN member banks, and IT businesses, is an open, flexible, enterprise-grade computing platform built on the Microsoft Azure cloud infrastructure. The exchange currently features over 65 standardized API definitions that allow banks to reduce the complexity of building and delivering open banking capabilities by providing clear guidance on how to implement innovative and intuitive digital services across both back-end and customer-facing functions. The BIAN API Exchange was built on Virtusa's Open Innovation Platform and features gamification to boost the right community behaviors. The gamified environment is designed to promote healthy and measurable meritocracy to enhance collaboration and contribution amongst the BIAN community. Further, the API Exchange will allow banks to modernize their critical legacy infrastructure and adopt standardized frameworks to facilitate more open and easy collaboration with FinTechs and RegTechs. BIAN's API Exchange also consists of community-building collaboration tools such as wikis, forums, and ideation billboards where API and microservice creators and consumers can collaborate dynamically to create and use BIAN-based API implementations.

10:01 EDT Medtronic reports FDA approves new SynchroMed II myPTM - Medtronic announced U.S. Food and Drug Administration approval of the new SynchroMed II myPTM Personal Therapy Manager for patients with chronic pain. "This device enables patients to alleviate their unpredictable pain by delivering on-demand boluses, or drug doses, within therapeutic limits set by their physician," the company said.

10:00 EDT Symbol now BKW falls -19.1% - Symbol now BKW is down -19.1%, or -$4.28 to $18.13.

10:00 EDT Lithia Motors rises 11.8% - Lithia Motors is up 11.8%, or $9.02 to $85.20.

10:00 EDT K12 rises 14.7% - K12 is up 14.7%, or $2.56 to $19.89.

09:58 EDT Ameresco partners with Douglas County for $2.2M GESPC contract - Ameresco announced that the company contracted with Douglas County for a $2.2M Guaranteed Energy Savings Performance Contract to provide energy efficiency and infrastructure upgrades to 38 municipal government buildings. Funded through energy and operational cost savings, the project is expected to save the County more than $164,000 annually, over the 15-year contract term. Ameresco is responsible for project development, design and engineering, construction management, as well as, energy savings measurement and performance verification, and training County staff on all installed equipment and systems. Once complete, the GESPC is expected to reduce County energy use by 1,588,002 kWh annually. This project consists of 11 energy conservation measures including replacing or retrofitting over 500 water fixtures, new rooftop units at the Fire Administration building, new air handling units at the Rideshare building, new direct digital controls, and smart irrigation systems. Ameresco will also replace or retrofit over 7,400 interior and exterior lighting fixtures. This project will improve building performance while lowering operation and maintenance costs. Additionally, new LED lighting and HVAC systems will improve air and light quality in the County's buildings.

09:56 EDT VBI Vaccines to present initial data for VBI-1901 in GBM at SNO meeting - VBI Vaccines announced that initial clinical data from the Phase 1/2a study of VBI-1901 in recurrent Glioblastoma, or GBM, patients will be presented in a poster discussion session at the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, or SNO, taking place November 15-18. "While early, the responses we've seen to-date are encouraging. The data to be presented at SNO will assess initial immunologic responses to vaccination with VBI-1901 in patients with recurrent GBM. We've already seen evidence of robust boosting of CMV-specific immunity directed against multiple antigens in some subjects in both the low and intermediate dose cohorts. As this is the first clinical data from our immuno-oncology vaccine candidate, we are honored and very pleased that the SNO has accepted our abstract for poster presentation and we look forward to the meeting," said David Anderson, VBI's Chief Scientific Officer. Following two positive Data Safety and Monitoring Board reviews that occurred in April and September 2018, detailed patient-specific data for subjects in the low- and intermediate-dose cohorts will be included in the presentation. Additional information will be available when abstracts are released from embargo on November 5, the company noted.

09:47 EDT Global Geoscience falls -9.8% - Global Geoscience is down -9.8%, or -$3.01 to $27.60.

09:47 EDT Tupperware Brands rises 8.8% - Tupperware Brands is up 8.8%, or $2.86 to $35.22.

09:47 EDT Knight-Swift rises 10.3% - Knight-Swift is up 10.3%, or $3.12 to $33.32.

09:34 EDT Secret Service intercepts suspicious packages sent to Clinton, Obama - The U.S. Secret Service said it has "intercepted two suspicious packages addressed to Secret Service protectees." Late on October 23, the Secret Service recovered a single package addressed to Former First Lady Hillary Clinton in Westchester County, New York. Early this morning, October 24, a second package addressed to the residence of Former President Barack Obama was intercepted by Secret Service personnel in Washington, D.C., said the agency in a statement. It added, "The packages were immediately identified during routine mail screening procedures as potential explosive devices and were appropriately handled as such. The protectees did not receive the packages nor were they at risk of receiving them. The Secret Service has initiated a full scope criminal investigation that will leverage all available federal, state, and local resources to determine the source of the packages and identify those responsible."

09:26 EDT UPS to have 70% of U.S. volume in automated facilities by end of year

09:24 EDT Amgen reports Phase 3 results of Enbrel monotherapy in psoriatic arthritis - Amgen announced 'positive' results from the Phase 3 SEAM-PsA study comparing the efficacy of Enbrel monotherapy and ENBREL plus methotrexate to methotrexate monotherapy in patients with psoriatic arthritis. The study was undertaken to address key knowledge gaps regarding the optimal use of methotrexate and TNF inhibitors such as ENBREL in patients with early disease who have not previously received treatment with biologics and methotrexate for PsA. Results showed that a significantly higher proportion of patients on ENBREL monotherapy and on combination therapy achieved the primary endpoint of ACR 20 response compared with patients on methotrexate monotherapy - 60.9% and 65.0% vs. 50.7%, respectively. A significantly higher proportion of patients on ENBREL monotherapy and on combination therapy also achieved Minimal Disease Activity, a key secondary endpoint, vs. patients on methotrexate monotherapy - 35.9% and 35.7% vs. 22.9%, respectively. Adverse events were generally balanced between the treatment groups. No new safety concerns were identified in this study. Additional Phase 3b results show the modified ENBREL formulation was associated with significantly lower mean injection site pain versus prior formulation.

09:15 EDT Hertz names InterGlobe Air Transport as exclusive General Sales Agent in India - Hertz Global Holdings announced that its wholly owned subsidiary, The Hertz Corporation, has appointed InterGlobe Air Transport as its exclusive General Sales Agent in India. IGAT will manage the outbound sales of products and services of Hertz and its additional car rental brands Dollar, Thrifty, ACE and Firefly to domestic travel trade partners, corporate customers and leisure travellers. IGAT has 29 years of experience in the Indian travel industry, 12 sales offices and 80 sales people. The exclusive partnership was formed following a year of successful collaboration in India between the two companies.

09:11 EDT First Solar sells GA Solar 4 Project to Origis Energy - First Solar and Origis Energy announced that Origis Energy has acquired the GA Solar 4 Project from First Solar. The 200MWAC photovoltaic solar generation asset, located in Twiggs County, Georgia, near Warner Robins, is expected to be the largest solar power plant in the southeastern United States when completed. Terms of the deal were not disclosed. Origis will sell all energy and renewable attributes of the project to Georgia Power through Georgia Power's Renewable Energy Development Initiative, or REDI, program. Construction of the 2,000-acre project is expected to begin in early November and will consist of more than half a million of First Solar's advanced technology thin film solar modules on single axis tracker mounts. The largest infrastructure project in Twiggs County, this build will create up to 400 construction jobs and ongoing tax revenues.

09:08 EDT AT&T: Path to historical leverage ratio includes growing EBITDA, paying debt - Sees 2.5x range by YE2019; historical levels by YE2022. Says sees debt reduction funded by FCF growth. Additional opportunities include non-core asset sales; Capital markets options under consideration. Expects to have retired or refinanced ~$28B of near-term maturities by year end. Says hedged against rising rates, about 90% of debt is fixed-rate.

09:07 EDT Origis Energy acquires 200MWac GA Solar 4 Project from First Solar - First Solar and Origis Energy USA announced that Origis Energy has acquired the GA Solar 4 Project from First Solar. The 200MWAC photovoltaic solar generation asset, located in Twiggs County, Georgia, near Warner Robins, is expected to be the largest solar power plant in the southeastern United States when completed. Terms of the deal were not disclosed. Origis will sell all energy and renewable attributes of the project to Georgia Power through Georgia Power's Renewable Energy Development Initiative program. Construction of the 2,000-acre project is expected to begin in early November 2018, and will consist of more than half a million of First Solar's advanced technology thin film solar modules on single axis tracker mounts. The largest infrastructure project in Twiggs County, this build will create up to 400 construction jobs and ongoing tax revenues.

09:02 EDT Finjan's InvinciBull acquires Anonymizer customers - Finjan Holdings announced that its subsidiary, Finjan Mobile, Inc.'s newly launched enhanced VPN, InvinciBull is acquiring the Anonymizer user-base of Ntrepid Corporation. InvinciBull is a set-it-once VPN designed to stream content and data securely anonymously wherever you are on the planet.

08:57 EDT Fly Intel: Pre-market Movers - UP AFTER EARNINGS: Trivago (TRVG), up 15%... Boeing (BA), up 4.6%... Tupperware (TUP), up 9%... Amphenol (APH), up 5%. ALSO HIGHER: Alexion (ALXN), up 4% after the company and Dicerna Pharmaceuticals (DRNA) announced a collaboration to discover and develop RNA interference therapies for complement-mediated diseases. DOWN AFTER EARNINGS: Texas Instruments (TXN), down 6%... UPS (UPS), down 4%... Boston Scientific (BSX), down 4%... AT&T (T), down 3%... iRobot (IRBT), down 8%... Six Flags (SIX), down 10%... STMicroelectronics (STM), down 11%.

08:48 EDT Pareteum's 36-month contractual revenue backlog reaches $500M - Pareteum's current 36-month contractual revenue backlog has grown to $500M, including the backlog incorporated with Pareteum's recent acquisition of Artilium and excluding certain monthly recurring revenue streams deriving from that acquisition for which long-term contracts are not in place. This milestone for Pareteum represents a 1,150% increase year over year since 2016: at year end 2016, Pareteum announced $40M 36MCRB; at year end 2017, the company announced $147M. During the same period, Pareteum's quarterly booked revenue increased by 260%.

08:43 EDT AT&T says 'committed to stabilizing EBITDA' in 2019

08:40 EDT AT&T says feels 'very good' about cash flow heading into Q4 - Says sees 4Q18 reimbursement of $1.3B as FirstNet has approved the latest contract milestones.

08:37 EDT AT&T reports Q3 free cash flow $6.5B - Reports $12.3B cash from ops, up 14%. Reports YTD free cash flow of $14.4B.

08:36 EDT AT&T says growth being 'heavily driven' by prepaid business - Comments from Q3 earnings conference call.

08:34 EDT Peak Resorts reports pre-season season pass revenue increased 22% - Peak Resorts provided updated preliminary results for pre-season sales of its 2018/2019 Peak Pass. Through the October 19 pre-season pricing deadline, Peak Pass sales increased by approximately 19% on a unit basis and by approximately 22% on a revenue basis, compared to the prior year. The year-to-date sales of Peak Pass products include continued strong sales of the Drifter Pass, the company's unlimited pass option for 18 to 29-year-olds, which will remain on sale at its discounted rate until December 15. Results exclude pre-season snow time buy-ups and pass sales which will continue until October 31.

08:32 EDT Syntiant raises $25M in Series B funding round led by Microsoft's M12 - Syntiant Corp., an artificial intelligence semiconductor company that is creating an entirely new class of ultra-low-power, high-performance, deep neural network processors for edge computing, announced it has raised $25M in Series B funding led by M12, Microsoft Corp.'s (MSFT) venture fund. Other strategic investors that participated in the raise include the Amazon Alexa Fund (AMZN), Applied Ventures, Intel Capital (INTC), Motorola Solutions Venture Capital (MSI) and Robert Bosch Venture Capital.

08:27 EDT Agile Therapeutics announces SECURE study presentation at NAFFP - Agile Therapeutics announced an oral presentation regarding predictors of pregnancy in the Phase 3 SECURE study of the investigational low-dose, once-weekly contraceptive patch, AG200-15. The company presented the new analyses at the North American Forum on Family Planning. The presentation included detailed findings of statistical modeling performed to identify variables predictive of pregnancy in the SECURE study. The abstract is published in the October issue of Contraception.

08:18 EDT Catalyst Biosciences receives notice of allowance from Japanese Patent Office - Catalyst Biosciences announced that it has received a notice of allowance from the Japan Patent Office for claims in the company's international patent PCT/US2013/032616, covering modified Factor X polypeptides and the uses thereof. The patent includes claims that cover modified coagulation Factor X polypeptides, including Factor Xa and other forms of Factor X and use of modified Factor X polypeptides for certain bleeding disorders.

08:14 EDT Apple CEO Tim Cook: Privacy is a 'fundamental human right' - Apple CEO Tim Cook tweeted: "It was an honor to be invited to #ICDPPC2018 in Brussels this morning. I'd like to share a bit of what I said to this gathering of privacy regulators from around the world. It all boils down to a fundamental question: What kind of world do we want to live in? GDPR has shown us all that good policy and political will can come together to protect the rights of everyone. We believe that privacy is a fundamental human right. No matter what country you live in, that right should be protected in keeping with four essential principles: First, companies should challenge themselves to de-identify customer data or not collect that data in the first place. Second, users should always know what data is being collected from them and what it's being collected for. This is the only way to empower users to decide what collection is legitimate and what isn't. Anything less is a sham. Third, companies should recognize that data belongs to users and we should make it easy for people to get a copy of their personal data, as well as correct and delete it. And fourth, everyone has a right to the security of their data. Security is at the heart of all data privacy and privacy rights. Technology is capable of doing great things. But it doesn't want to do great things. It doesn't want anything. That part takes all of us. We are optimistic about technology's awesome potential for good - but we know that it won't happen on its own." Reference Link

08:08 EDT Judge denies Teva's motion to dismiss Corcept's patent infringement claims - Corcept Therapeutics Incorporated (CORT) announced that Judge Susan Wigenton of the United States District Court for the District of New Jersey has denied Teva Pharmaceuticals USA, Inc.'s (TEVA) motion to dismiss a lawsuit brought by Corcept alleging infringement of patents relating to the use of Korlym, Corcept's medication for the treatment of patients with endogenous Cushing's syndrome. Corcept has sued Teva for infringement of two patents covering Korlym upon receipt of notice in February 2018 that Teva is seeking approval from the United States Food & Drug Administration to market a generic version of Korlym. In July 2018, Corcept filed an amended complaint asserting a third patent against Teva. Judge Wigenton's denial of Teva's motion means that Corcept's lawsuit will proceed. "We are gratified by today's decision," said Joseph K. Belanoff, MD, Corcept's CEO, "and look forward to developing and presenting our case to the Court. We will vigorously enforce our intellectual property rights."

08:05 EDT Boeing up 4.7% to $366.50 after Q3 results beat estimates, FY18 guidance raised

08:04 EDT Westwater Resources 'applauds' EPA's action to withdraw rule change - The company said, "Westwater Resources is pleased to report that the US Environmental Protection Agency has withdrawn a rule change proposed in 2017 for groundwater restoration that afforded no new protection for the environment, but only promised to raise costs for the uranium industry if enacted. Westwater Resources is nearing the completion of reclamation at two sites, and this EPA action is an important affirmation that ongoing work to reclaim future operations will not be impacted by poorly conceived rules that offer no positive impact on groundwater quality and only succeed in increasing the costs of restoration. Westwater remains committed to the safety of the environment and the public at our operations, and compliance with sensible and effective rules are key to this promise. On Friday, October 19, 2018, the EPA said that its existing rules were sufficient for the protection of public health and safety from radiological and non-radiological hazards associated with uranium and thorium ore processing. EPA's acting administrator Andrew Wheeler cast the proposed rule change as 'unnecessary and punishing' on uranium producers...Westwater Resources thanks the National Mining Association for their able leadership in the effort to achieve this action."

08:02 EDT Ford, Fiat Chrysler, Nissan car ads banned by U.K. watchdog - Advertisements for cars produced by Ford, Fiat Chrysler and Nissan have been banned in the U.K. after it was found that the messages promoted reckless driving. Two advertisements for Ford, shown only in movie theaters and on YouTube, featured a voice over that quoted a Dylan Thomas poem with the lines "Do not go gently into that goodnight. Old age should burn and rave at close of day. Rage. Rage against the dying of the light." The Advertising Standards Authority found that the ad helped to suggest "that driving was a way of releasing anger, which put the driver, other motorists and pedestrians at risk." In the case of Fiat Chrysler, a YouTube ad that featured four cars racing at high speed has also had one complaint upheld against it. Nissan has also been told it must not feature an ad again in its current form after a viewer complained that the message encouraged dangerous driving by "exaggerating the benefit of the vehicle's safety features." Reference Link

07:58 EDT Boeing raises FY18 Global Services revenue view to $16B-$16.5B from $15.5B-$16B

07:56 EDT Boeing raises FY18 Commercial Airplanes operating margin view to 12%-12.5% - Prior view was greater than 11.5%.

07:50 EDT KemPharm presents two posters on KP415 HAP trials at AACAP - KemPharm announced the presentation of posters from two human abuse potential, or HAP, trials for its KP415 prodrug candidate to treat attention deficit hyperactivity disorder, or ADHD. The posters will be presented at the American Academy of Child and Adolescent Psychiatry, or AACAP. The first poster reported data from the intravenous, or IV, HAP clinical trial of SDX, KemPharm's novel prodrug of d-methylphenidate, or d-MPH and the major active pharmaceutical ingredient (API) in KP415, an investigational product for the treatment of ADHD. The results of this 30-subject trial demonstrated that IV administration of SDX yielded minimal exposure to d-MPH and was statistically similar to placebo on multiple standard abuse-related endpoints, suggesting that SDX is unlikely to be attractive for IV abuse. The second poster reported results from a study designed to identify the optimal intranasal, or IN, dose of d-MPH that was subsequently used as the active comparator in a study evaluating the IN-abuse potential of SDX. The results of this six-subject study demonstrated that 40 mg of d-MPH produced an optimal balance of drug liking/good effects and bad effects in recreational stimulant abusers, and thus was selected as the positive control in the IN HAP study of SDX.

07:44 EDT LabCorp cuts FY18 free cash flow view to $975M-$1.025B from $1.1B-$1.2B - Lowered guidance primarily due to the upcoming tax payment of approximately $125M related to the disposition of the Food Solutions business, which was not included in the prior guidance.

07:38 EDT Intrexon forms bioinformatics hub in Munich - Intrexon announced the formation of Intrexon Bioinformatics Germany GmbH, a Munich-based bioinformatics company. Now a part of IBG, the Munich-based group of bioinformatics industry members have developed software tools focused on mapping genomic, transcriptomic, and epigenomic function in eukaryotic microbes and multicellular organisms employing diverse experimental inputs. Their bioinformatics software solutions are designed to enable scientists to develop a model of biological "reality" from which to design both Discovery and Applied Research experiments.

07:37 EDT Boeing CEO says 'captured important new defense business' in Q3 - "Our teams continued to perform at a high level during the quarter, driving solid operating performance and robust cash generation, and continuing to deliver on our One Boeing advantage by bringing the best of Boeing to our customers," said Boeing Chairman, President and CEO Dennis Muilenburg. During the quarter we captured important new defense business, winning and investing in the MQ-25 and T-X programs and securing the MH-139 contract, clearly demonstrating the value Boeing brings to customers while positioning us well for future growth opportunities. Within the Commercial Airplanes business, the 777X static test airplane was completed and moved into test setup and the team's focus on execution across our production programs continued to drive outstanding performance and strong operating margins. Our Global Services business continues to deliver on total lifecycle value to our customers, with key wins in the quarter including P-8 Poseidon training contracts for the U.S. Navy and Royal Australian Air Force and an order from GECAS for 20 737-800 Boeing Converted Freighters. Additionally, we began integrating new data analytics tools, powered by Boeing AnalytX, into all Boeing Defence Australia support contracts, enhancing its position as a leading fleet services provider in the region. This strong underlying performance, along with growth across our businesses we've seen throughout the year, give us confidence to raise our 2018 revenue and earnings guidance and reaffirm our operating cash flow guidance."

07:34 EDT Amneal Pharmaceuticals issued new patent for investigational Parkinson's formula - Amneal Pharmaceuticals has been issued a patent protecting IPX203 by the USPTO. The patent covers controlled release formulations of levodopa and uses thereof. IPX203 is an investigational extended-release oral capsule formulation of carbidopa and levodopa, being studied as a potential treatment for the symptoms of advanced Parkinson's disease.

07:32 EDT General Dynamics reports Q3 backlog $69.5B, up 4.9% from Q2 - The company's total backlog at the end of third-quarter 2018 was $69.5B, up 4.9% from second-quarter 2018. The estimated potential contract value, representing management's estimate of value in unfunded indefinite delivery, indefinite quantity contracts and unexercised options, was $34.7B. Total potential contract value, the sum of all backlog components, was $104.2B at the end of the quarter, a new record. Order activity was robust across the company with a 1.4-to-1 total book-to-bill ratio, defined as orders divided by revenue.

07:22 EDT BeiGene announces zanubrutinib NDA acceptance from China NMPA - BeiGene announced the acceptance by the China National Medical Products Administration, or NMPA, of a new drug application, or NDA, for zanubrutinib, an investigational Bruton's tyrosine kinase, or BTK, inhibitor, for the treatment of patients with relapsed/refractory, or R/R, chronic lymphocytic leukemia, or CLL, or small lymphocytic lymphoma, or SLL. Zanubrutinib was discovered in BeiGene's research facilities in Beijing, China, and is being developed globally by BeiGene as a monotherapy and in combination with other therapies to treat various hematologic malignancies. In August, the NMPA accepted BeiGene's first NDA for zanubrutinib for the treatment of patients with R/R mantle cell lymphoma, or MCL. The NDA is supported by an extensive clinical, non-clinical and chemistry, manufacturing and control data package, including the results from a 91-patient single-arm pivotal Phase 2 study in Chinese patients with R/R CLL/SLL treated with zanubrutinib, dosed at 160 mg orally twice daily. An independent review of response data from this study, with a data cut-off of June 15 and a median follow-up of 9.1 months, showed an overall response rate, or ORR of 80%, inclusive of complete response, partial response and partial response with lymphocytosis. The median duration of response has not been reached, as a majority of the responders remain in a response. The safety profile was consistent with previously reported clinical data for zanubrutinib. Updated data with additional follow-up of the patients in the study will be submitted to the NMPA as an additional document of the NDA and are planned to be presented at an upcoming medical conference. Zanubrutinib is being evaluated in a broad global registration program, including a fully enrolled Phase 3 clinical trial in patients with WM, comparing zanubrutinib with ibrutinib, the currently approved BTK inhibitor for WM. Zanubrutinib is also being studied in comparison to bendamustine/ rituximab in a Phase 3 clinical trial in patients with previously untreated CLL/SLL, as well as in a pivotal randomized Phase 2 trial in combination with Gzayva in patients with R/R follicular lymphoma. In China, besides the pivotal Phase 2 trials in R/R MCL and R/R CLL/SLL, BeiGene has completed enrollment in a pivotal Phase 2 clinical trial in patients with WM. BeiGene also plans to initiate a Phase 3 trial comparing zanubrutinib to ibrutinib in patients with R/R CLL/ SLL.

07:18 EDT Dunkin' taking on Starbucks with new espresso offerings - Dunkin' said it is "now determined to be known for great-tasting espresso beverages. Nearly one month after unveiling its new rebranding designed to emphasize its beverage-focused strategy, Dunkin' revealed one of the most significant product initiatives in the brand's recent history, with the goal of offering an entirely new espresso experience for customers in its U.S. restaurants by the holiday season. With new state-of-the-art espresso equipment, a new espresso recipe, extensive restaurant training and new espresso cups, Dunkin' will serve handcrafted hot and iced espresso beverages -- including lattes and cappuccinos -- featuring a rich, smooth, balanced taste that meets the profile preferred by espresso customers, and in particular younger espresso drinkers. Dunkin's enhanced espresso experience includes the installation of new equipment in all participating U.S. restaurants that dramatically improves espresso bean extraction for the optimal espresso beverage. The resulting espresso will deliver a stronger and more robust flavor profile. In preparation for the launch, Dunkin' restaurant employees throughout the country have received extensive training and espresso certification on the new equipment and beverage builds." Earlier this year, Dunkin' Brands announced plans to invest approximately $100M into the Dunkin' U.S. business, more than half of which is committed to restaurant equipment that will enable the company to accelerate its beverage-led strategy, including espresso. With Dunkin' franchisees also making a substantial investment in the initiative, the brand is focused on growing its share of the hot and iced espresso category.

07:13 EDT Attunity wins $1M expansion deal with Fortune 100 manufacturer - Attunity announced that a Fortune 100 manufacturing company has purchased additional licenses and services for nearly $1M to expand its use of Attunity Replicate and add a new license for Attunity Compose for Hive.

07:11 EDT New York Community Bancorp approves $300M common share repurchase program - New York Community Bancorp has approved the repurchase of $300M of the company's outstanding common stock. The program will be funded by a planned issuance of up to $300M of subordinated debt.

07:07 EDT Helius Medical anounces partnership with Feinstein Institute - Helius Medical Technologies announced that its wholly owned subsidiary, NeuroHabilitation Corporation, has partnered with Northwell Health's Feinstein Institute for Medical Research in Manhasset, NY. This partnership will enable Helius to implement its second Clinical Experience Program for its Portable Neuromodulation Stimulator -- an investigational medical device in the US currently under review for market clearance by the US Food & Drug Administration. PoNS is a licensed class II medical device in Canada. The CEP will be performed at three of Northwell Health's clinical sites including North Shore University Hospital and Transitions of Long Island in Manhasset, NY and Southside Hospital in Bay Shore, NY.

07:06 EDT Trivago now sees FY18 adjusted EBITDA flat-(EUR10M) - Previous adjusted EBITDA view was (EUR 30M)-(EUR 15M).

07:03 EDT Lithia Motors reports Q3 total SSS up 1%

06:58 EDT AT&T reports Q3 mobility highlights - Mobility: Service revenues up 2.3% on a comparable basis. 550,000 phone net adds in the U.S. 69,000 postpaid phone net adds. 481,000 prepaid phone net adds. Nearly 750,000 branded smartphones added to base. Third-quarter postpaid phone churn of 0.93%.

06:56 EDT RPC, Inc. declares special year-end cash dividend of 7c per share - RPC, Inc. announced that its board declared a special year-end cash dividend of 7c per share. The dividend is payable December 10 to common stockholders of record at the close of business on November 9.

06:54 EDT Cubic to acquire Trafficware for $235.7M - Cubic announced that it has entered into an agreement to acquire Advanced Traffic Solutions, a leading provider of intelligent traffic solutions for the transportation industry, for approximately $235.7 million in cash, subject to customary adjustments. Based in Sugar Land, TX., Trafficware provides a fully integrated, innovative suite of software, Internet of Things devices and hardware solutions that provide customers with enhanced mobility and improved safety. Trafficware will be integrated into the Cubic Transportation Systems business unit. The acquisition is expected to close today, October 24, subject to customary closing conditions. In fiscal year 2019, Trafficware is expected to contribute approximately $50 million in sales and $14 million to $15 million of Adjusted EBITDA. Cubic anticipates the transaction will be accretive to cash earnings per share in the first full year of operations, exclusive of transaction fees. Cubic will finance the transaction from borrowings under its revolver.

06:50 EDT ChromaDex's Tru Niagen daily serving increased after NDI notification from FDA - ChromaDex increased the capsule serving of its flagship Tru Niagen nutrient to 150mg, two per day, following successful New Dietary Ingredient notification from FDA. Niagen was clinically-studied at 300mg to increase NAD in 2016, published in the journal Nature Communications. Since then, three additional clinical studies have published on Niagen and 18 additional clinical studies on ChromaDex's patented ingredient are planned or in progress. Niagen has received two successful New Dietary Ingredient notifications, the second reviewed at 300mg, as well as Generally Recognized as Safe notification to the FDA.

06:47 EDT Restaurant Brands intends to repurchase 10M Class B partnership units - Restaurant Brands and Restaurant Brands International Limited Partnership, or RBI LP, announced the receipt of an exchange notice from 3G Restaurant Brands Holdings, an affiliate of 3G Capital Partners, to exchange 11,106,925 Class B exchangeable limited partnership units of RBI LP. RBI LP intends to satisfy this notice with the repurchase of 10M exchangeable units for cash and the delivery of 1,106,925 common shares of the company. The repurchase of exchangeable units for cash is anticipated to be financed with available cash on hand. The exchange date will occur on November 6 and the repurchase of exchangeable units for cash will be based on the 20-day volume weighted average price of the company's common shares traded on the NYSE in U.S. dollars, in accordance with the terms of the limited partnership agreement of RBI LP. Also per the terms of the limited partnership agreement, RBH has until October 30 to revoke its exchange notice, in part or in full, after which time the exchange notice will become irrevocable. No partners of 3G Capital are reducing their ownership directly or indirectly in the transaction.

06:44 EDT Northrop Grumman: Q3 results include first full quarter of Innovation Systems - The third quarter includes the first full quarter of Innovation Systems results. These additional earnings were partially offset by pre-tax merger-related expenses of $97 million. Third quarter 2018 earnings also include a pre-tax benefit of $223 million resulting from the settlement of cost claims.

06:43 EDT Northrop Grumman raises FY18 free cash flow view to $2.5B-$2.7B - Prior view was $2.4B-$2.6B.

06:37 EDT Alexion raises FY18 outlook

06:34 EDT Owens Corning lowers 2018 adjusted EBIT view to $855M from $925M-$975M - Owens Corning continues to expect an environment consistent with consensus expectations for U.S. housing starts and global industrial production growth. In Insulation, lowers EBIT growth view to $110M from $150M. . Continues to expect to achieve $120M of price. The primary driver of the downward revision in the outlook is related to weaker market expectations across geographies and product platforms. In Roofing, now expects U.S. asphalt shingle market to be down 10% on lower storm demand. Q3 industry shipments were reported down 19%, and company volumes were ahead of the market. Price improvements have recovered asphalt and transportation inflation, driving EBIT margins to 20% in the quarter. In Composites, expects growth in the glass fiber market, driven by global industrial production growth. However, continued inflation as well as lower than expected volumes in the U.S. roofing market, Europe, and India have reduced the EBIT expectation to approximately $260M. Estimates effective tax rate of 26%-28%, and cash tax rate of 10%-12% on adjusted pre-tax earnings. Expects general corporate expenses $125M-$130M, down from previous estimate $135M-$140M. Capital additions in 2018 are expected to total approximately $500M. Interest expense is expected to be $125M-$130M. In 2018, continues to expect strong conversion of adjusted earnings into free cash flow, although it will now be less than the company's target of about 100%.

06:27 EDT Deutsche Bank reports Q3 Corporate & Investment Bank revenues EUR3B - Net revenues for the Corporate Investment Bank were 3.0 billion euros, down 13% versus the prior year quarter. Global Transaction Banking revenues were down 5% year-on-year, due to changes in the business perimeter. Net revenues for the Private & Commercial Bank were 2.5 billion euros, down 3% versus the prior year quarter, primarily reflecting the non-recurrence of a positive effect of 108 million euros from the sale of Concardis GmbH in the third quarter of 2017.

06:20 EDT American Finance Trust comments on MacKenie Realty Capital's mini-tender offer - American Finance Trust, or AFIN, announced that, after careful evaluation, its board of directors strongly recommends that AFIN's stockholders reject the latest unsolicited mini-tender offer launched by MacKenzie Realty Capital and certain of its affiliates to purchase up to 400,000 shares of each of AFIN's Class A and Class B-2 common stock. The company said, "AFIN became aware of MacKenzie's latest offer when MacKenzie issued a press release on October 10, 2018. AFIN does not endorse MacKenzie's offer and reminds its stockholders that MacKenzie is not affiliated with AFIN or AFIN's advisor. MacKenzie is a for-profit business that we believe opportunistically timed this offer to commence with the simultaneous conversion of AFIN's Class B-1 common stock into AFIN's Class A common stock traded on The Nasdaq Global Select market ("Nasdaq"). While there can never be any assurance as to AFIN's future stock price, management is confident about AFIN's portfolio, growth potential and the stockholder value that solid execution of its business and investment strategy will bring. MacKenzie has had limited success in acquiring shares from AFIN's stockholders in previous mini-tender offers. AFIN's board of directors believes that the latest MacKenzie offer is not in the best interest of AFIN's stockholders, because, among other reasons: Opportunistic Attempt to Profit at Stockholders' Expense. AFIN's board of directors believes that MacKenzie's offer represents yet another opportunistic attempt by MacKenzie to make a profit by purchasing shares across both share classes at what we believe could well prove to be undervalued prices, thereby depriving the stockholders who tender shares in the MacKenzie offer of distributions paid by the company to you after September 17, 2018 and of potential stock appreciation after the date the tender paperwork is accepted by MacKenzie. We believe that MacKenzie would not be making the offer if it did not think AFIN's shares will be worth more in the future than the prices they are paying for each share class. Deceptive Offer Price. MacKenzie will reduce the actual price paid for tendered shares by any distributions paid on such shares by AFIN after September 17, 2018, which are currently paid at a rate of $1.10 per year per share. As a result, the per share price actually paid by MacKenzie will be at least $0.18 less than their offer price if MacKenzie's offer expires on November 16, 2018. The actual amount paid could be reduced further depending on when MacKenzie accepts the tendered shares or if MacKenzie's offer is extended at its discretion. MacKenzie's Offer Avoids Important Investor Protections and Disclosure. The latest MacKenzie offer has not been publicly filed and avoids important investor protections and disclosure. In fact, the SEC has cautioned investors about mini-tender offers, noting that "[s]ome bidders make mini-tender offers at below-market prices, hoping that they will catch investors off guard..." The SEC has also published investor tips regarding mini-tender offers on its website at: http://www.sec.gov/investor/pubs/minitend.htm. The MacKenzie offer avoids important investor protections, including by accepting tenders only on a first come, first served basis with no right to withdraw or rescind a tender, even if the MacKenzie offer is extended. As a result, once MacKenzie receives it, a tender is irrevocable. Unlike tender offers required to be filed with the SEC, the MacKenzie offer materials in our opinion fail to adequately address certain matters, including: a complete description of the risks associated with the MacKenzie offer; a clear discussion of the methodologies used by MacKenzie to determine its offer price or how it has valued AFIN's shares; completeness of disclosure as to the identity of MacKenzie, its control persons and promoters; and a clear disclosure of AFIN shares owned by MacKenzie and its affiliates. AFIN believes that each stockholder must individually evaluate whether to tender his, her or its shares. The AFIN board suggests stockholders carefully consider all the factors discussed in the limited MacKenzie offer materials before deciding to participate, including consulting with any financial or tax advisors when considering the MacKenzie offer. AFIN appreciates its stockholders' trust in the company and its board of directors and thanks them for their continued support. AFIN encourages its stockholders to follow the board of directors' recommendation to not tender shares in the latest MacKenzie offer. If you do not wish to tender shares in the MacKenzie offer, simply do not respond."

06:12 EDT ForeScout and Belden partner for industrial environment security - ForeScout (FSCT) has teamed up with Belden (BDC) to provide organizations with solutions to mitigate detrimental impacts to safety, quality and productivity in their industrial automation and control networks caused by cyber events. ForeScout formed a strategic alliance with Belden companies, Tripwire, a provider of industrial control system security-focused technologies featuring the Tripwire Industrial Suite, and Hirschmann.

06:09 EDT Mesoblast expands partnership with JCR Pharma in Japan for wound healing - Mesoblast has expanded its partnership with JCR Pharmaceuticals in Japan for wound healing in patients with Epidermolysis Bullosa. JCR has received Orphan Designation for the allogeneic mesenchymal stem cell product Temcell HS Inj1 in the treatment of EB. Based on results from an investigator-initiated trial in Japan, JCR intends to seek label extension for Temcell in Japan beyond its existing approval for the treatment of acute graft versus host disease. Under the expanded License Agreement covering EB, Mesoblast has provided JCR with access to its patent portfolio for the use of mesenchymal stem cells in wound healing. Mesoblast will receive royalties on Temcell product sales for EB. Additionally, Mesoblast has the right to use safety and efficacy data generated by JCR in Japan in support of development and commercialization of its MSC product candidate remestemcel-L for EB and other non-healing wound indications in the United States and other major healthcare markets.

06:06 EDT TRI Pointe expects to deliver 5,0125-5,130 homes at average price of $635K - For Q4, the company expects to open 19 new communities, and close out of 14, resulting in 130 active selling communities as of December 31. In addition, the company anticipates delivering 80% to 85% of its 2,101 units in backlog as of September 30 at an average sales price of $640K. For the full year, the company expects to deliver between 5,025 and 5,130 homes at an average sales price of $635K. The company anticipates its homebuilding gross margin percentage will be in a range of 20.0% to 20.5% for Q4, resulting in a FY18 range of 21.0% to 21.5%. Expects its SG&A expense as a percentage of home sales revenue to be in the range of 8.8% to 9.2% for Q4, resulting in a FY18 range of 10.1% to 10.5%.

06:04 EDT Hilton sees FY19 system-wide RevPAR up 2%-4% - Full year 2019 system-wide RevPAR is expected to increase between 2.0%-4.0% on a comparable and currency neutral basis compared to 2018; net unit growth is expected to be approximately 6%-7%.

06:01 EDT Hilton reports Q3 System-wide comparable RevPAR increased 2% - System-wide comparable RevPAR increased 2.0% on a currency neutral basis for the third quarter from the same period in 2017.

05:40 EDT Travelport expands partnership with IBM - Travelport (TVPT) announced it is expanding its longstanding partnership with IBM (IBM) to further develop innovations designed to disrupt the travel industry. Travelport has completed a proof of concept to streamline the validation, distribution and settlement of hotel content between its own platform, travel agencies and hotels, through IBM Blockchain. Separately, Travelport is turning to the IBM Watson Data Platform to personalize customer experiences with new tools and traveller recommendations.In the first of two programs, Travelport is moving into the next phase of development using IBM Blockchain to streamline the hotel and in-trip experience ecosystem. Providing choices through content, seamless booking and fulfilment experience is crucial to traveller satisfaction. In recent years, travelers' interest in unique experiences, as they look for content to share on social media platforms, has grown. Through blockchain, travellers, experience providers and hotels can see notable benefits around the management and increased availability of so called 'long tail content'. Travel agencies, whether brick-and-mortar, online or corporate travel managers, have faced many challenges with 'long tail content' due to the diverse nature of travel services and products, the large number of travel suppliers and their limited technical capabilities. Processing settlements across a diverse range of suppliers can be complicated and the entire process to reach a completed transaction often takes time. Consequently, agencies are often unable to sell the content due to issues in traveller experience and the cost of processing. Likewise, those content suppliers are frustrated with limited capability in providing offers and experiences to travellers before they arrive at the hotel. Together, Travelport and IBM determined that by using blockchain, content could be managed to provide travel agencies confidence in the travel experience and ease of sale, while also enabling long-tail content suppliers to participate efficiently.

05:31 EDT Veoneer appoints Nishant Batra as Chief Technology Officer - Veoneer has appointed Nishant Batra to the new position as Executive Vice President and Chief Technology Officer, or CTO, and is refining its management and reporting structure within the Electronics Segment. Batra has been appointed EVP and CTO. Most recently, he was head of Network Products within Ericsson. Batra will join Veoneer in mid-November.

05:20 EDT Teledyne appoints COO Al Pichelli as CEO, Robert Mehrabian named chairman - The board of Teledyne Technologies announced today that Robert Mehrabian will be named Executive Chairman, effective January 1, 2019. As Executive Chairman, Dr. Mehrabian will remain actively involved with the company with a particular focus on strategy, technology, mergers and acquisitions and margin expansion programs. Dr. Mehrabian's employment contract has been amended and extended an additional four years to December 2023. In addition, Teledyne's President and COO, Al Pichelli, will assume the title of President and Chief Executive Officer. Pichelli has entered into an employment agreement through December 2021.